Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

UK AstraZeneca vaccine plant partially evacuated over suspect package

Police forensic officers work outside the Wockhardt pharmaceutical plant in Wrexham, Britain January 27, 2021. REUTERS/Phil Noble

A factory in Wales that produces AstraZeneca's COVID-19 vaccine was partially evacuated on Wednesday after it received a suspicious package and police said a bomb disposal unit was dealing with the incident.

Operated by Wockhardt UK, the plant provides so-called fill-and-finish capacity for AstraZeneca's UK supply chain, which is the final manufacturing step of putting vaccines into vials or syringes and packaging them.

AstraZeneca has agreed to supply Britain with 100 million doses of the vaccine, developed by Oxford University.

A police forensic officer walks past a bomb disposal unit van outside the Wockhardt pharmaceutical plant in Wrexham, Britain January 27, 2021. REUTERS/Phil Noble

It is currently engaged in a dispute with the European Union after it cut supplies to the bloc due to production issues at its Belgian factory.

"Wockhardt UK in Wrexham this morning received a suspicious package to site. All relevant authorities were immediately notified and engaged," the company said, referring to its facility outside the town of Wrexham in north Wales.

"Upon expert advice we have partially evacuated the site pending a full investigation. The safety of our employees and business continuity remain of paramount importance," it said.

General view of the Wockhardt pharmaceutical plant near Wrexham, Britain, January 27, 2021. Picture taken with a drone. REUTERS/Phil Noble

Local police confirmed that a bomb disposal unit was on site and advised the public to avoid the area.

"We are currently dealing with an ongoing incident on the Wrexham Industrial Estate," they said in a statement.

A police vehicle stands outside the Wockhardt pharmaceutical plant in Wrexham, Britain January 27, 2021. REUTERS/Phil Noble

(Reporting by Alistair Smout, Michael Holden and Guy Faulconbridge; Editing by Estelle Shirbon and David Clarke)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.